Cell Therapy
Cell therapies are uniquely sensitive to process design, material variability, and manufacturing execution. Small changes in activation, expansion, or formulation can significantly impact product performance and regulatory outcomes.
How Artis Executes Cell Therapy Programs
Our translational model connects development and GMP execution from the start. Process and analytical teams work alongside manufacturing and quality groups, reducing tech transfer risk and preserving process knowledge across program stages.